| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 2,970,040 | 3,425,770 | 2,372,314 | | Cost of Revenue | 1,726,202 | 1,992,200 | 1,389,060 | | | Gross Profit | 1,243,838 | 1,433,570 | 983,254 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 733,687 | 761,980 | 566,118 | | Non Recurring | 4,343 | 1,280 | 8,865 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 505,808 | 670,310 | 408,271 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (58,808) | (9,910) | 12,399 | | Earnings Before Interest And Taxes | 447,000 | 660,400 | 420,670 | | Interest Expense | 2,384 | 2,690 | 2,678 | | Income Before Tax | 444,616 | 657,710 | 417,992 | | Income Tax Expense | 108,394 | 197,280 | 104,678 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 336,222 | 460,430 | 313,314 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 336,222 | 460,430 | 313,314 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $336,222 | $460,430 | $313,314 |
|
0.83% Nasdaq 0.00%
Income Statement
